Literature DB >> 20006516

Synthesis and anti-viral activity of azolo-adamantanes against influenza A virus.

Vladimir V Zarubaev1, Efim L Golod, Pavel M Anfimov, Anna A Shtro, Victor V Saraev, Alexey S Gavrilov, Alexander V Logvinov, Oleg I Kiselev.   

Abstract

Chemotherapy and chemoprophylaxis of influenza is one of the most important directions of health protection activity. Due to the high rate of drug-resistant strains of influenza virus, there is a need for the search and further development of new potent antivirals against influenza with a broad spectrum of activity. In the present study, a set of di-, tri- and tetrazole derivatives of adamantane was efficiently prepared and their anti-influenza activities evaluated against rimantadine-resistant strain A/Puerto Rico/8/34. In general, derivatives of tetrazole possessed the highest virus-inhibiting activity. We demonstrated that several compounds of this set exhibited much higher activity than the currently used antiviral rimantadine, a compound of related structure. Moreover, we showed that these azolo-adamantanes were significantly less toxic. This study demonstrates that influenza viruses can be inhibited by adamantyl-azoles and thus have potential for developing antiviral agents with an alternate mechanism of action. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20006516     DOI: 10.1016/j.bmc.2009.11.047

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  10 in total

1.  Exploring the size limit of templates for inhibitors of the M2 ion channel of influenza A virus.

Authors:  María D Duque; Chunlong Ma; Eva Torres; Jun Wang; Lieve Naesens; Jordi Juárez-Jiménez; Pelayo Camps; F Javier Luque; William F DeGrado; Robert A Lamb; Lawrence H Pinto; Santiago Vázquez
Journal:  J Med Chem       Date:  2011-04-05       Impact factor: 7.446

2.  Heterocyclic Inhibitors of Viroporins in the Design of Antiviral Compounds.

Authors:  Vadim A Shiryaev; Yuri N Klimochkin
Journal:  Chem Heterocycl Compd (N Y)       Date:  2020-07-17       Impact factor: 1.277

Review 3.  Tetrazoles via Multicomponent Reactions.

Authors:  Constantinos G Neochoritis; Ting Zhao; Alexander Dömling
Journal:  Chem Rev       Date:  2019-02-01       Impact factor: 60.622

4.  (2SR,3RS)-Methyl 2-(adamantan-1-yl)-3-phenyl-sulfonyl-3-(pyridin-2-ylsulfan-yl)propano-ate dichloro-methane hemisolvate.

Authors:  Rosa-Luisa Meza-León; Sylvain Bernès; Elsie Ramírez Domínguez; Martha Sosa-Rivadeneyra; Leticia Quintero-Cortés
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-03-26

5.  Application of different chemometric tools in QSAR study of azolo-adamantanes against influenza A virus.

Authors:  R Karbakhsh; R Sabet
Journal:  Res Pharm Sci       Date:  2011-01

6.  15N-Labelling and structure determination of adamantylated azolo-azines in solution.

Authors:  Sergey L Deev; Alexander S Paramonov; Tatyana S Shestakova; Igor A Khalymbadzha; Oleg N Chupakhin; Julia O Subbotina; Oleg S Eltsov; Pavel A Slepukhin; Vladimir L Rusinov; Alexander S Arseniev; Zakhar O Shenkarev
Journal:  Beilstein J Org Chem       Date:  2017-11-29       Impact factor: 2.883

7.  Synthesis and antiviral activity of nonannulated tetrazolylpyrimidines.

Authors:  Vladimir А Ostrovskii; Gevorg G Danagulyan; Olga M Nesterova; Yulia N Pavlyukova; Vladimir V Tolstyakov; Olga S Zarubina; Pavel А Slepukhin; Yana L Esaulkova; Anna А Muryleva; Vladimir V Zarubaev; Rostislav E Trifonov
Journal:  Chem Heterocycl Compd (N Y)       Date:  2021-05-14       Impact factor: 1.490

8.  Synthesis, structure, and antiviral properties of novel 2-adamantyl-5-aryl-2H-tetrazoles.

Authors:  Olga V Mikolaichuk; Vladimir V Zarubaev; Anna А Muryleva; Yana L Esaulkova; Daria V Spasibenko; Alina А Batyrenko; Ilya V Kornyakov; Rostislav Е Trifonov
Journal:  Chem Heterocycl Compd (N Y)       Date:  2021-05-26       Impact factor: 1.277

Review 9.  New small-molecule drug design strategies for fighting resistant influenza A.

Authors:  Zuyuan Shen; Kaiyan Lou; Wei Wang
Journal:  Acta Pharm Sin B       Date:  2015-09-06       Impact factor: 11.413

Review 10.  Anti-Influenza Treatment: Drugs Currently Used and Under Development.

Authors:  Luciano Amarelle; Emilia Lecuona; Jacob I Sznajder
Journal:  Arch Bronconeumol       Date:  2016-08-09       Impact factor: 4.872

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.